Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| epithelial cell | 5 studies | 25% ± 7% | |
| naive B cell | 4 studies | 17% ± 3% | |
| astrocyte | 4 studies | 28% ± 6% | |
| glutamatergic neuron | 4 studies | 40% ± 14% | |
| oligodendrocyte | 4 studies | 26% ± 6% | |
| B cell | 3 studies | 23% ± 1% | |
| endothelial cell | 3 studies | 19% ± 2% | |
| adipocyte | 3 studies | 21% ± 3% | |
| GABAergic neuron | 3 studies | 37% ± 5% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 35% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 1748.42 | 1445 / 1445 | 99% | 15.13 | 182 / 183 |
| breast | 100% | 1898.01 | 459 / 459 | 98% | 10.57 | 1093 / 1118 |
| lung | 100% | 1588.03 | 577 / 578 | 97% | 7.51 | 1126 / 1155 |
| stomach | 100% | 1436.49 | 359 / 359 | 97% | 8.94 | 278 / 286 |
| thymus | 100% | 1699.36 | 653 / 653 | 97% | 7.61 | 585 / 605 |
| prostate | 100% | 1578.33 | 245 / 245 | 97% | 9.20 | 485 / 502 |
| ovary | 100% | 1454.93 | 180 / 180 | 95% | 6.07 | 408 / 430 |
| intestine | 100% | 1866.21 | 966 / 966 | 94% | 6.42 | 498 / 527 |
| brain | 99% | 1264.80 | 2618 / 2642 | 95% | 5.74 | 671 / 705 |
| pancreas | 100% | 1169.98 | 327 / 328 | 94% | 5.44 | 168 / 178 |
| bladder | 100% | 1566.86 | 21 / 21 | 93% | 5.71 | 469 / 504 |
| skin | 100% | 1673.59 | 1809 / 1809 | 92% | 5.81 | 434 / 472 |
| uterus | 100% | 1517.37 | 170 / 170 | 92% | 5.95 | 420 / 459 |
| kidney | 100% | 1474.44 | 89 / 89 | 91% | 6.46 | 823 / 901 |
| liver | 100% | 1536.28 | 226 / 226 | 90% | 5.22 | 364 / 406 |
| adrenal gland | 100% | 1161.54 | 258 / 258 | 71% | 2.55 | 164 / 230 |
| adipose | 100% | 1797.09 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 1503.45 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 100% | 3101.86 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 1753.96 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 2.27 | 1 / 1 |
| heart | 97% | 1012.66 | 834 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 92% | 894.91 | 851 / 929 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 91% | 8.48 | 41 / 45 |
| eye | 0% | 0 | 0 / 0 | 70% | 2.78 | 56 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 66% | 4.60 | 19 / 29 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0010719 | Biological process | negative regulation of epithelial to mesenchymal transition |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0005634 | Cellular component | nucleus |
| GO_0046983 | Molecular function | protein dimerization activity |
| GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
| GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
| Gene name | USF3 |
| Protein name | Basic helix-loop-helix domain-containing protein USF3 (Upstream transcription factor 3) Upstream transcription factor family member 3 |
| Synonyms | KIAA2018 |
| Description | FUNCTION: Involved in the negative regulation of epithelial-mesenchymal transition, the process by which epithelial cells lose their polarity and adhesion properties to become mesenchymal cells with enhanced migration and invasive properties. . |
| Accessions | ENST00000491165.5 Q68DE3 ENST00000316407.9 ENST00000478658.1 C9JBW0 |
